Results 81 to 90 of about 24,493 (268)

Idiopathic Retroperitoneal Fibrosis [PDF]

open access: yesJournal of the American Society of Nephrology, 2016
Idiopathic retroperitoneal fibrosis (RPF), reviewed herein, is a rare fibro-inflammatory disease that develops around the abdominal aorta and the iliac arteries, and spreads into the adjacent retroperitoneum, where it frequently causes ureteral obstruction and renal failure.
Vaglio A, Maritati F
openaire   +2 more sources

Muscle Loss in Obesity Therapy as a Therapeutic Target: Trial Design and Endpoints for Regulatory Discussions

open access: yesJournal of Cachexia, Sarcopenia and Muscle, Volume 16, Issue 6, December 2025.
ABSTRACT The Society on Cachexia and Wasting Disorders (SCWD) convened a Regulatory and Trial Update Workshop in Washington, D.C., in December 2024, assembling experts from academic institutions, the pharmaceutical industry and the US Food and Drug Administration (FDA) for focused discussions.
Stephan von Haehling   +7 more
wiley   +1 more source

New cases expand the genotype, phenotype and therapeutic landscape of H syndrome

open access: yes
British Journal of Haematology, EarlyView.
Clément Triaille   +10 more
wiley   +1 more source

Clinical Presentation, Treatment, and Outcomes of 28 Patients With Castleman Disease: A Retrospective Analysis of an Italian Cohort

open access: yeseJHaem, Volume 6, Issue 6, December 2025.
ABSTRACT Background Castleman disease (CD) encompasses a range of heterogeneous non‐clonal lymphoproliferative disorders, including unicentric (UCD), and multicentric (MCD) forms. The latter is subdivided into HHV‐8+ MCD, POEMS‐MCD, and idiopathic‐MCD, not otherwise specified (iMCD‐NOS).
Caterina Cristinelli   +14 more
wiley   +1 more source

Successful mycophenolate mofetil therapy in nine patients with idiopathic retroperitoneal fibrosis [PDF]

open access: yes, 2017
Objective. To assess the therapeutic benefit of mycophenolate mofetil (MMF) in retroperitoneal fibrosis (RF). Methods. MMF 2 g/day and prednisone 1 mg/kg were initiated in nine patients with radiological (9/9) and histological verification (2/9) of ...
Adler, S.   +3 more
core  

Retroperitoneal Fibrosis: Beware of Lymphoma [PDF]

open access: diamond, 2021
Mohamed Ouchani   +4 more
openalex   +1 more source

Vertebral Growth Modulation Through Periosteal Resection and Fixed Length Deformity Overcorrection: Computational and In Vivo Pilot Study

open access: yesJOR SPINE, Volume 8, Issue 4, December 2025.
The feasibility of using growth promoting strategies (vertebral periosteal resection and distraction) was investigated via computational and in vivo analysis. Computational analysis demonstrated that there is an increasing mechanical benefit to utilizing concave distraction over convex compression during spinal deformity correction.
Matthew A. Halanski   +10 more
wiley   +1 more source

Musculoskeletal Diseases: Mechanisms and Therapeutic Advances

open access: yesMedComm, Volume 6, Issue 12, December 2025.
Musculoskeletal diseases comprise a broad spectrum of inflammatory, degenerative, and neoplastic disorders. Increasing evidence highlights the central role of immune regulation in their pathogenesis, with complex interactions among immune, bone, muscle, and stromal cells.
Xiao Ma   +17 more
wiley   +1 more source

Vascular thromboses with retroperitoneal fibrosis: a case report [PDF]

open access: gold, 2022
Hanane Charaf   +6 more
openalex   +1 more source

Large‐Bore Vacuum Suction Biopsy of Pediatric Soft Tissue Tumors: A 5‐Year Retrospective Analysis of Safety and Effectiveness

open access: yesPediatric Blood &Cancer, Volume 72, Issue 12, December 2025.
ABSTRACT Introduction Percutaneous large‐bore vacuum suction biopsy (LBVSB) is an innovative alternative to open surgical biopsy and minimally invasive image‐guided percutaneous core needle biopsy (PCNB) for pediatric soft tissue tumors. This study reviews our experience using this modality.
Abhinav R. Balu   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy